Alpha-1-acid glycoprotein (AGP) or orosomucoid (ORM) is a 41–43-kDa glycoprotein with a
pI of 2.8–3.8. The peptide moiety is a single chain of 183 amino acids (human) or 187 amino …

α1-Acid glycoprotein (AGP) is a protein with a molecular weight of 41–43kDa and is heavily
glycosylated (45%). Due to the presence of sialic acids, it is negatively charged (pI= 2.7 …

Orosomucoid (ORM) is an acute-phase protein that belongs to the immunocalin subfamily, a
group of small-molecule-binding proteins with immunomodulatory functions. Little is known …

Glycosylation is one of the most important post-translational modifications of proteins, and
has been widely acknowledged as one of the most important ways to modulate both protein …

A subset of the lipocalins, notably α1-acid glycoprotein, α1-microglobulin, and glycodelin,
exert significant immunomodulatory effects in vitro. Interestingly, all three are encoded from …

Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease
pathogenesis Page 1 Disease Markers 25 (2008) 219–232 219 IOS Press Glycosylation …

α1-acid glycoprotein (orosomucoid, AGP) is an Acute Phase Protein produced by liver and
peripheral tissues in response to systemic reaction to inflammation. AGP functions have …

The glycosylation of the acute phase glycoprotein alpha 1-acid glycoprotein (AGP) in human
sera is subject to marked changes during acute inflammation as a result of the cytokine …

Orosomucoid (OMD) contains complex bi-, tri-and tetra-antennary glycan chains.
Subfractionation of OMD into three molecular variants using concanavalin A lectin …

The aim of this review is to summarize the research efforts of the last two decades with
respect to (i) the determination and characterization of the changes in glycosylation of AGP …